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ABSTRACT
Trypanosoma cruzi is the causative agent of Chagas disease. Nowadays, the transmission 
in Brazil occurs mainly by oral ingestion of contaminated food that has been associated with 
more severe clinical manifestations. We report a case of Acute Chagas disease caused by oral 
transmission in a child from Northern Brazil. In the hospital admission, physical examination 
showed tachycardia, hepatomegaly, bipalpebral edema and anasarca. Trypanosoma cruzi 
trypomastigotes were found in microscopy during blood cell count. Twenty-three days 
before hospitalization, the child had ingested the “bacaba palm fruit’s wine”. Even with the 
appropriate diagnosis and starting of treatment, she did not survive. Quantitative analysis of 
Trypanosoma cruzi DNA in a blood sample resulted in 54,053.42 parasite equivalents/mL 
and the DTU TcIV was identified. The outcome may have been determined by several factors, 
including the delay to seek a medical service beyond the high parasitemia, detected by qPCR. 
DTU TcIV could also have influenced the natural history of the disease. 
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INTRODUCTION
Chagas disease (CD) is a vector borne disease caused by Trypanosoma cruzi 
(T. cruzi). The clinical course of Chagas disease is usually divided into an acute 
phase and a chronic phase. The acute phase immediately follows infection. In 
the past, the disease was transmitted mostly by infected feces deposited during 
the vector blood meal. In addition to vector-borne transmission, T. cruzi may be 
transmitted through blood transfusion, organ solid and stem cels transplantation. 
In spite of advances in vector and transfusion control programs especially from 
Intergovernmental initiatives triggered in the 1990s. Chagas disease still remains 
an important public health problem due to congenital transmission and ingestion 
of contaminated food1. Acute Chagas disease (ACD) is characterized by an acute 
febrile syndrome associated with nonspecific signs and symptoms similar to other 
tropical diseases such as malaria, visceral leishmaniasis and typhoid fever2. If 
undetected and untreated, its mortality can reach 10% of the cases3. Chagas disease 
(CD) is a neglected disease and the measures necessary for its prevention, diagnosis 
and treatment are far from ideal. Its prevalence is unclear due to underreporting 
and the spatial heterogeneity of the zoonotic cycle4. In Brazil, most ACD cases 
occur in the Amazon Region whose vast area, with immense biodiversity, limits 
surveillance and vector control. Besides, the access to health services is precarious. 
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In this region, the main source of infection is the oral 
ingestion of contaminated food, such as açaí (Euterpe 
oleracea) or bacaba palm fruit (Oenocarpus bacaba). 
Recently, an increase in the number of cases has been 
recorded despite the initiatives of artisanal products quality 
control5. Detection of acute phase infections is relatively 
uncommon due to the nonspecific clinical symptoms 
observed in most infected patients. Frequently, only the 
more severely affected patients are diagnosed in this 
phase6. Direct examination of stained thick blood smears 
are widely used in the Brazilian Amazon region due to the 
practicality, low cost and availability7. Currently, access to 
PCR for detection of acute phase infections or reactivations 
is limited and, in general, not available in the areas where 
oral transmission is more frequent. The Faculdade de 
Medicina of the Universidade de Sao Paulo, SP, maintain 
in the city of Santarem, Para State, Brazil, the Nucleus of 
Tropical Medicine (NUMETROP), with a small team of 
medical doctors specialized in tropical diseases.
We report an ACD case that occurred in the municipality 
of Santarem, Para State, Brazil, in a 22 months-old infant, 
after the oral ingestion of bacaba palm fruit’s wine. Correct 
but late diagnosis and treatment were insufficient to save her 
life, indicating the need for better management and methods 
that could help clinicians. Another eight cases of ACD were 
diagnosed in the same riverside community. 
CASE REPORT
NUMETROP infectious physicians of the Hospital 
Municipal de Santarem admitted a 22 female months-
old infant, in April 2016, in a fair general condition, 
with bipalpebral edema and anasarca. She was from the 
Riverside community of Marimarituba, municipality of 
Santarem, Para State, far from Santarem downtown eight 
hours by boat. The parents refered she has had fever, 
vomiting, diarrhea and upper abdominal pain thirteen days 
before the hospital admission (Figure 1). Homogeneous 
central rash, heart rate of 112 bpm and liver at 2 cm 
below the costal margin were observed in the physical 
examination. 
Admission exams results: Hemoglobin 10.2 g/dL, 
h e m a t o c r i t  2 8 . 4 % ,  7 , 8 0 0  l e u k o c y t e s / m m 3, 
4,602 lymphocytes/mm3, platelets 102,000/mm3, positive 
blood smear with visualization of T. cruzi trypomastigotes. 
When asked, the parents reported that twenty-three days 
before hospitalization, the child had ingested the “bacaba 
palm fruit’s wine”, corresponding to Day 0 in Figure 1. 
She was the first patient detected in an outbreak with more 
eight infected individuals detected. Additional exams 
showed AST 83 U/L, ALT 55 U/L. Normal Chest X-ray. 
Electrocardiogram: inversion of the T wave in V1-V3. On 
day 24, treatment was initiated with orally administrated 
Benznidazole (10 mg/kg/day, three times a day), and no 
side effects were noticed. She was discharged asymptomatic 
with negative blood smear on day 10 of Benznidazole, due 
to social reasons. 
Her parents were oriented to return if there was 
worsening of the clinical picture. A 60-day treatment 
was prescribed, but the patient suddenly died three days 
later (Figure 1). Necropsy was not available. The indirect 
immunofluorescence (IF) tests, which were performed in 
the LACEN (Central Laboratory of Public Health of Para), 
were positive for anti-T.cruzi IgG antibodies (titer 1/160) 
and for IgM antibodies (titer 1/80). 
Other specific tests for the diagnosis of ACD were 
collected after 5 days of Benznidazole and carried out in 
a research laboratory at the Faculdade de Medicina of the 
Universidade de Sao Paulo, that supports NUMETROP, 
after the the parents’ authorization. The study was 
approved by the Research Ethics Committee of Faculdade 
de Medicina of the Universidade de Sao Paulo, process 
Nº 2695.519.
The Laboratory of Medical Research in Immunology 
of the Hospital das Clinicas of the Universidade de Sao 
Paulo, that supports NUMETROP, carried out in house 
molecular tests. 
Quantitative PCR
Quantitative PCR (qPCR) for T. cruzi detection was 
performed following previously described methodology8. 
Figure 1 - Evolution of the patient from the ingestion of “bacaba palm fruit’s wine” until the fatal outcome. 
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T. cruzi was typed using two different parasite genomic 
sequences.
24Sα ribosomal (rRNA) gene D7 domain
The hemi-nested PCR was performed as previously 
described9 with modifications: D75 and D76 primers were 
used in first round and D71 and D72 primers were used 
in the second round. Amplifications were performed in a 
GenePro Thermal Cycler (Hangzhou Bioer Technology 
Co., Ltd., China), as follows: first round, touchdown hold 
(95 °C for 3 min); 6 cycles (94 °C for 60 s; 64 °C for 60 s; 
72 °C for 60 s; reducing the annealing temperature by 2 °C 
each 2 cycles); 29 cycles (94 °C for 60 s; 58 °C for 60’s; 
72 °C for 60 s). The second round parameters were: 94 ºC 
for 3 min; 3 cycles (94 ºC for 30 s, 60 ºC for 30 s, 72 ºC 
for 30 s); 3 cycles (94 ºC for 30 s, 57 ºC for 30 s, 72 ºC for 
30 s); 20 cycles (94 ºC for 30 s, 55 ºC for 30 s, 72 ºC for 
30 s). Amplicons of 110-bp are characteristic of TcI/TcIII 
DTU; 125-bp of TcII/TcVI; 110+125-bp of TcV and 120 
or 130 of TcVI. 
Spliced leader genes intergenic region (mini-exon 
gene) 
DNA was amplified according to the previously 
described multiplex protocol10: Three oligonucleotides, 
derived from a hypervariable region of the T. cruzi mini-
exon repeat and an oligonucleotide from a specific region of 
the T. rangeli nontranscribed spacer were used as upstream 
primers. A common oligonucleotide, designed in the most 
conserved part of the miniexon, was used as the downstream 
primer. Amplicons of 150-bp are characteristic of 
TcIII/TcIV DTU; 200-bp of TcI and 250-bp of TcII; TcV as 
well as TcVI and T. rangeli generated an amplicon of 100pb. 
Amplified products were visualized by means of a 
capillary gel electrophoresis apparatus (GelBot, Loccus 
Biotecnologia, Brazil). A high resolution cartridge S1 kit 
was applied (Loccus Biotecnologia, Brazil) and data were 
analyzed by means of the software Q-Analyzer. 
Trypanosoma cruzi, and Trypanosoma rangeli reference 
strains were used as markers of the six DTUs (Table 1). 
DISCUSSION
In this case report, it is important to highlight the variables 
that may have influenced the fatal outcome. Death among 
young people is described in ACD outbreaks11-13. Beyond the 
young age, her remarkable symptomatology, characterized 
by the presence of multiple clinical manifestations, 
compatible with the simultaneous involvement of several 
organs and systems, could be related to the fatality. 
This child presented fever, tachycardia, gastrointestinal 
manifestations (vomiting, diarrhea, hepatomegaly and 
upper abdominal pain), skin rash, anasarca whereas ACD 
is usually oligosymptomatic or asymptomatic2. Oral 
transmission of T. cruzi has been associated with more 
severe clinical outcome14 when the usual cause of death is 
frequently an acute myocarditis. However, fatal evolution 
due to stroke and upper gastrointestinal bleeding has also 
been described. Treatment was not initiated until 15 days 
after the beginning of the clinical manifestations. This delay 
may have contributed to the slower therapeutic response, 
given the extent of the illness15.
In addition, her laboratorial parameters showed low 
platelets and altered liver enzymes in parallel with the 
very high parasitemia. Taken together, all these factors 
contributed to the fatal evolution16. In the fatal case 
reported herein, the parasite load was extremely high 
(54,053.42 parasite equivalents/mL) by qPCR; this result 
is corroborated by a clinical study in which parasitic 
loads in ACD samples were higher than in chronic CD 
cases, reaching concentrations of up to 8 Log10 parasite 
equivalents/10 mL17. However, parasites were not detected 
Table 1 - Description of Trypanosoma cruzi and Trypanosoma rangeli reference strains used in this study and the respective gene 
sequences GenBank accession numbers. 
Species DTU Sample ID Host species
GeneBank accession number
SSUrDNA Cytochrome 
oxidase subunit II
Cathepsin L-like 
protein
T. cruzi
TcI JR cl4 H. sapiens HQ604893.1
TcII Y H. sapiens AF301912
TcIII MT3663 H. sapiens AF303060
TcIV JJ H. sapiens AY491761
TcV Bertha H. sapiens FJ555614
TcVI CL Brener T. infestans AF245383
T. rangeli Tra1719 A. planirostris JF421351
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by blood smear examination performed on the seventh day 
of Benznidazole treatment.
The genetic diversity of the parasite can probably have 
influenced the natural history of the disease, the diagnosis 
and the treatment of ACD18. T. cruzi specific DTU TcIVwas 
observed and is shown in Figures 2A and 2B. In the Amazon 
Basin, DTU TcI and IV are the usual T. cruzi DTUs found 
in isolates19. In experimental studies, TcIV showed higher 
virulence and fatality rate in shorter periods of time when 
compared to TcI20. The different behaviors of each DTU 
can possibly be associated with the severity of infections, 
and it is possible that in humans, TcIV may also be more 
virulent and associated with the fatal evolution observed 
in this child.
Nevertheless, the frequency of T. cruzi DTUs during 
outbreaks in the Amazon region is currently unknown. As 
a large amount of T. cruzi DNA is required for the DTU 
typing, methods such as hemoculture and xenodiagnosis 
are often used to increase the number of available parasites 
before DTU typing, which may select a faster multiplying 
DTU, masking the DTU typing result. In this study, the 
DTU typing was directly performed from the patient’s 
blood, eliminating this “masking effect”.
In a retrospective study carried out from 2009 to 2013, 
it was shown that the number of cases and the lethality 
of ACD represents a serious public health problem in 
Brazil12 and from an economical point of view it is worth 
paying attention and investing on fighting Chagas disease. 
It is also important that research laboratories contribute to 
the diagnosis and to increase information on the parasite 
complexity, which can potentially improve the quality of 
medical care, avoiding outcomes as unfavorable as the one 
described in this report.
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